Tested Applications
| Positive WB detected in | HT-29 cells |
| Positive IHC detected in | human intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16738-1-AP targets BAIAP2L2 in WB, IHC, IF, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag9904 Product name: Recombinant human BAIAP2L2 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 168-518 aa of BC015619 Sequence: FVSESQRAAELEEKRRYRFLAEKHLLLSNTFLQFFGRARGMLQNRVLLWKEQSEASRSPSRAHSPGLLGPALGPPYPSGRLTPTRLDMPPRPLGEFSSPRSRHGSGSYGTEPDARPASQLEPDRRSLPRTPSASSLYSGSAQSSRSNSFGERPGGGGGARRVRALVSHSEGANHTLLRFSAGDVVEVLVPEAQNGWLYGKLEGSSASGWFPEAYVKALEEGPVNPMTPVTPMTSMTSMSPMTPMTPMNPGNELPSRSYPLRGSHSLDDLLDRPGNSTPSRVPSRAPSPAPPPLPSSRRSSMGSTAVATDVKKLMSSEQYPPQELFPRGTNPFATVKLRPTITNDRSAPLIR Predict reactive species |
| Full Name | BAI1-associated protein 2-like 2 |
| Calculated Molecular Weight | 518 aa, 58 kDa |
| Observed Molecular Weight | 57 kDa |
| GenBank Accession Number | BC015619 |
| Gene Symbol | BAIAP2L2 |
| Gene ID (NCBI) | 80115 |
| RRID | AB_2878309 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q6UXY1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for BAIAP2L2 antibody 16738-1-AP | Download protocol |
| WB protocol for BAIAP2L2 antibody 16738-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The BAIAP2L2 Polyclonal antibody (Cat# 16738-1-AP) has 4 total citations. These appear in Cancer Gene Therapy, Scientific Reports, Journal of Cellular Physiology, and Biomedical Pharmacotherapy. The associated research fields span oncology and cancer biology—covering hepatocellular carcinoma, lung adenocarcinoma, and gastric cancer progression and immune evasion—along with auditory biology, specifically BAIAP2L2's role in maintaining mechanotransducing stereocilia of cochlear hair cells. Applications cited include WB, IHC, IF, and CoIP.
| Species | Application | Title |
|---|---|---|
Cancer Gene Ther BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression
| ||
Sci Rep Comprehensive analysis of malignant subtypes of lung adenocarcinoma based on multi-omics landscape and functional validation of prognostic biomarker BAIAP2L2.
| ||
J Cell Physiol BAIAP2L2 is required for the maintenance of mechanotransducing stereocilia of cochlear hair cells.
| ||
Biomed Pharmacother BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/β-catenin signaling pathways.
|
